Ilumya Prices, Coupons and Patient Assistance Programs
Ilumya (tildrakizumab) is a member of the interleukin inhibitors drug class and is commonly used for Plaque Psoriasis and Psoriasis.
Ilumya Prices
This Ilumya price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Ilumya subcutaneous solution (100 mg/mL) is around $14,537 for a supply of 1 milliliter(s), depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Subcutaneous Solution
| Quantity | Per unit | Price |
|---|---|---|
| 1 milliliter(s) | $14,536.76 | $14,536.76 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Ilumya Coupons and Rebates
Ilumya offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Ilumya Copay Card: Eligible commercially insured patients may pay no more than $5 per dose; for additional information contact the program at 855-445-8692.
| Applies to: | Ilumya |
| Number of uses: | 12 months after program activation |
| Applies to: | Ilumya |
| Number of uses: | 24 months after program activation |
Patient Assistance Programs for Ilumya
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Ilumya (tildrakizumab-asmn) Injection; Subcutaneous
Provider: Ilumya Support Patient Assistance Program
Elligibility requirements:
- Uninsured or Underinsured
- At or below 400% of FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- This program also provides copay assistance.
Applicable drugs:
- Ilumya (tildrakizumab-asmn) Injection; Subcutaneous
More about Ilumya (tildrakizumab)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 3 Reviews
- Drug class: interleukin inhibitors
- FDA Approval History
